Aureus Asset Management’s ResMed RMD Stock Holding History

Aureus Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,022	Closed	-$229K	–	253
2026 Q1	$229K	Hold	1,022	–	–	0.02%	207
2025 Q4	$246K	Hold	1,022	–	–	0.02%	173
2025 Q3	$280K	Hold	1,022	–	–	0.02%	167
2025 Q2	$264K	Hold	1,022	–	–	0.02%	173
2025 Q1	$229K	Hold	1,022	–	–	0.02%	187
2024 Q4	$234K	Hold	1,022	–	–	0.02%	190
2024 Q3	$249K	Buy	+1,022	New	+$228K	0.02%	179
2024 Q2	–	Sell	-1,022	Closed	-$202K	–	211
2024 Q1	$202K	Buy	+1,022	New	+$187K	0.01%	190
2021 Q1	–	Sell	-961	Closed	-$204K	–	195
2020 Q4	$204K	Buy	+961	New	+$192K	0.02%	179

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Aureus Asset Management's RMD Position: Q2 2026 in Review

Aureus Asset Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,022 shares — an estimated $229K sold.

Aureus Asset Management first reported a position in RMD in Q4 2020 and held it in 9 quarters. The position peaked at $280K in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Aureus Asset Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
Aureus Asset Management sold 1,022 ResMed shares in Q2 2026, an estimated $229K.
Aureus Asset Management first reported a position in ResMed in Q4 2020 and held it in 9 quarters.
Aureus Asset Management's ResMed position peaked at $280K in Q3 2025.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Aureus Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.